These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24011804)
21. Calcium restores the macrophage response to nontypeable haemophilus influenzae in chronic obstructive pulmonary disease. Provost KA; Smith M; Arold SP; Hava DL; Sethi S Am J Respir Cell Mol Biol; 2015 Jun; 52(6):728-37. PubMed ID: 25338285 [TBL] [Abstract][Full Text] [Related]
22. IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Roos AB; Sethi S; Nikota J; Wrona CT; Dorrington MG; Sandén C; Bauer CM; Shen P; Bowdish D; Stevenson CS; Erjefält JS; Stampfli MR Am J Respir Crit Care Med; 2015 Aug; 192(4):428-37. PubMed ID: 26039632 [TBL] [Abstract][Full Text] [Related]
23. Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial. Wilkinson TMA; Schembri S; Brightling C; Bakerly ND; Lewis K; MacNee W; Rombo L; Hedner J; Allen M; Walker PP; De Ryck I; Tasciotti A; Casula D; Moris P; Testa M; Arora AK Vaccine; 2019 Sep; 37(41):6102-6111. PubMed ID: 31447126 [TBL] [Abstract][Full Text] [Related]
24. Interleukin-22 protects against non-typeable Haemophilus influenzae infection: alteration during chronic obstructive pulmonary disease. Sharan R; Perez-Cruz M; Kervoaze G; Gosset P; Weynants V; Godfroid F; Hermand P; Trottein F; Pichavant M; Gosset P Mucosal Immunol; 2017 Jan; 10(1):139-149. PubMed ID: 27143304 [TBL] [Abstract][Full Text] [Related]
25. Multi-site placebo-controlled randomised clinical trial to assess protection following oral immunisation with inactivated non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease. Clancy RL; Dunkley ML; Sockler J; McDonald CF Intern Med J; 2016 Jun; 46(6):684-93. PubMed ID: 27009822 [TBL] [Abstract][Full Text] [Related]
26. Budesonide Inhibits Intracellular Infection with Non-Typeable Haemophilus influenzae Despite Its Anti-Inflammatory Effects in Respiratory Cells and Human Lung Tissue: A Role for p38 MAP Kinase. Wagner C; Goldmann T; Rohmann K; Rupp J; Marwitz S; Rotta Detto Loria J; Limmer S; Zabel P; Dalhoff K; Drömann D Respiration; 2015; 90(5):416-25. PubMed ID: 26452008 [TBL] [Abstract][Full Text] [Related]
27. Lung Surfactant Lipids Provide Immune Protection Against García-Fojeda B; González-Carnicero Z; de Lorenzo A; Minutti CM; de Tapia L; Euba B; Iglesias-Ceacero A; Castillo-Lluva S; Garmendia J; Casals C Front Immunol; 2019; 10():458. PubMed ID: 30936871 [TBL] [Abstract][Full Text] [Related]
28. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. Berenson CS; Garlipp MA; Grove LJ; Maloney J; Sethi S J Infect Dis; 2006 Nov; 194(10):1375-84. PubMed ID: 17054066 [TBL] [Abstract][Full Text] [Related]
29. Type I interferon induced by DNA of nontypeable Haemophilus influenza modulates inflammatory cytokine profile to promote susceptibility to this bacterium. Yang S; Yin Y; Xu W; Zhang X; Gao Y; Liao H; Hu X; Wang J; Wang H Int Immunopharmacol; 2019 Sep; 74():105710. PubMed ID: 31255879 [TBL] [Abstract][Full Text] [Related]